PrimeLine® IN5 Respiratory Vaccine

Huvepharma introduces PrimeLine® IN5 - the first and only intranasal BRD vaccine with a label claim “effective against mortality caused by Mannheimia haemolytica” as well as protection against respiratory disease caused by IBR, BRSV, PI3, Pasteurella multocida and Mannheimia haemolytica.  PrimeLine IN5 is comprised of the most CURRENT MODIFIED LIVE VIRAL AND ATTENUATED LIVE BACTERIAL COMPONENTS for immune stimulation and is safe to use in calves 3 days of age or older.

INDICATIONS: This product has been shown to be effective for the vaccination of healthy cattle, 3 days of age or older, against respiratory disease caused by IBR, PI3,

BRSV, Mannheimia haemolytica and Pasteurella multocida. Duration of immunity has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

This product has been shown to be effective against mortality caused by Mannheimia haemolytica.

The presence of maternal antibody is known to interfere with the development of active immunity in cattle and additional boosters will be required in most young animals. For advice on revaccination frequency, consult your veterinarian.

ADMINISTRATION: Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 2 mL intranasally (IN) using a cannula in a single nostril. Healthy cattle should be vaccinated a minimum of 14 days prior to weaning, shipping, or exposure to stress or infectious conditions.

CAUTIONARY STATEMENTS: Inactivate unused contents before disposal. Use entire contents when first opened. Do not vaccinate within 21 days of slaughter. Do not mix with other products, except as specified on this label. Do not use in pregnant cows or calves nursing pregnant cows. In case of human exposure contact a physician.  Shedding of IBR vaccine virus may occur for 16 days after vaccination. Shedding of PI3 vaccine virus may occur for 9 days after vaccination. Store at 2-8° C (35-46° F).

Product contains streptomycin.